These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2046084)

  • 1. Incidence of ovarian cyst formation in women taking ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms.
    Friedman AJ; Wheeler JM
    J Reprod Med; 1991 Apr; 36(4 Suppl):345-9. PubMed ID: 2046084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms, with an emphasis on contraceptive efficacy. A phase IV trial.
    Friedman AJ; Wheeler J
    J Reprod Med; 1991 Apr; 36(4 Suppl):328-33. PubMed ID: 2046081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexion changes in oral contraceptive users. Results from a phase IV multicenter trial evaluating the safety and efficacy of ethynodiol diacetate, 1 mg, with ethinyl estradiol, 35 micrograms.
    Wheeler JM; Malinak LR
    J Reprod Med; 1991 Apr; 36(4 Suppl):340-4. PubMed ID: 2046083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of breakthrough bleeding during oral contraceptive therapy.
    Hill GA; Wheeler JM
    J Reprod Med; 1991 Apr; 36(4 Suppl):334-9. PubMed ID: 2046082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Follicular ovarian cysts appearing during progestin or estroprogestin oral contraception at low doses].
    Netter A; Gabriel R
    Bull Acad Natl Med; 1988 May; 172(5):711-5. PubMed ID: 3056584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two monophasic oral contraceptives: gestodene/ethinyl estradiol versus desogestrel/ethinyl estradiol.
    Benagiano G
    Int J Fertil; 1989 Sep; 34 Suppl():31-9. PubMed ID: 2576255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of ethynodiol diacetate, 1 mg, plus ethinyl estradiol, 35 micrograms. A phase IV trial. Introduction.
    Friedman AJ
    J Reprod Med; 1991 Apr; 36(4 Suppl):323-4. PubMed ID: 2046079
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estrogen-progestin contraception. Disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex; 1993 Jun; 21(6):481-8. PubMed ID: 7920935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
    Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
    Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception.
    Tayob Y; Adams J; Jacobs HS; Guillebaud J
    Br J Obstet Gynaecol; 1985 Oct; 92(10):1003-9. PubMed ID: 3902074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
    Akerlund M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epistaxis secondary to oral contraceptive.
    Man A; Segal S
    Acta Otolaryngol; 1981; 92(3-4):383-4. PubMed ID: 7324906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ovarian activity, cycle behavior and tolerance of low dosage oral contraceptives: a comparative study].
    Rossmanith WG; Wirth U; Gasser S; Thun B; Steffens D
    Zentralbl Gynakol; 1997; 119(11):538-44. PubMed ID: 9480608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cyst formation in patients using tamoxifen for breast cancer.
    Metindir J; Aslan S; Bilir G
    Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colposcopic findings in women treated with oral estrogen-progestagens].
    Gacci G
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1575-80. PubMed ID: 5744200
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.